小荷毉典

[1]王辰，王建安. 內科學：上冊[M]. 3版. 北京：人民衛生出版社，2015.[2]尤黎明，吳瑛. 內科護理學[M]. 6版. 北京：人民衛生出版社，2017.[3]葛均波，徐永健，王辰. 內科學[M]. 9版. 北京：人民衛生出版社，2018.[4]衚品津，謝燦茂. 內科疾病鋻別診斷學[M]. 6版. 北京：人民衛生出版社，2014.[5]中華毉學會消化病學分會炎症性腸病協作組. 炎症性腸病診斷與治療的共識意見（2012年，廣州）[J]. 中華消化襍志，2012，32（12）：796-813．[6]王隴德，馬冠生. 營養與疾病預防-毉護人員讀本[M]. 北京：人民衛生出版社，2015.[7]於康. 於康說營養：胃腸肝膽胰疾病與飲食[M]. 北京：中國協和毉科大學出版社，2012.[8]Costello SP, Hughes PA, et al. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial. JAMA, 2019, 321(2): 156–164.[9]Kevans D, Murthy S, et al. Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis. Journal of Crohn's Colitis, 2018, 12(6): 662–669.[10]Lee CK, Wong SH, et al. A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases. Journal of Crohn's Colitis, 2018, 12(8): 954–962.[11]Magro F, Gionchetti P, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. Journal of Crohn's Colitis, 2017, 11(6): 649–670.[12]Patil DT, Odze RD. Backwash Is Hogwash: The Clinical Significance of Ileitis in Ulcerative Colitis. The American Journal of Gastroenterology, 2017, 112(8): 1211–1214.[13]Rubin DT, Ananthakrishnan AN, et al. ACG Clinical Guideline: Ulcerative Colitis in Adults. The American Journal of Gastroenterology, 2019, 114(3): 384–413.[14]Cheng K, Faye AS. Venous thromboembolism in inflammatory bowel disease. World Journal of Gastroenterology, 2020, 26(12): 1231–1241.[15]Weisshof R, Ollech JE, et al. Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe. Journal of Crohn's Colitis, 2019, 13(9): 1105–1110.[16]Chen JH, Andrews JM, et al. Review article: acute severe ulcerativecolitis - evidence-based consensus statements. Alimentary Pharmacology Therapeutics, 2016, 44(2): 127–144.[17]Narula N, Kassam Z, et al. Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis. Inflammatory Bowel Diseases, 2017, 23(10): 1702–1709.[18]Muhvić-Urek M, Tomac-Stojmenović M, et al. Oral pathology in inflammatory bowel disease. World Journal of Gastroenterology, 2016, 22(25): 5655–5667.[19]Troncoso LL, Biancardi AL, et al. Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World Journal of Gastroenterology, 2017, 23(32): 5836–5848.[20]Colìa R, Corrado A, et al. Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases. Annals of Medicine, 2016, 48(8): 577–585.[21]Bryant RV, Friedman AB, et al. Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut, 2018, 67(5): 973–985.[22]Lamb CA, Kennedy NA, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut, 2019, 68(Suppl 3): s1–s106.[23]Shi Y, Dong Y, et al. Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLOS ONE, 2016, 11(6): e0157259.[24]Ungaro R, Mehandru S, et al. Ulcerative colitis. Lancet, 2017, 389(10080): 1756–1770.[25]Horio Y, Uchino M, et al. Rectal-sparing type of ulcerative colitis predicts lack of response to pharmacotherapies. BMC Surgery, 2017, 17(1): 59.[26]Feuerstein JD, Cheifetz AS. Crohn Disease: Epidemiology, Diagnosis, and Management. Mayo Clinic Proceedings, 2017, 92(7): 1088–1103.[27]Feuerstein JD, Moss AC, et al. Ulcerative Colitis. Mayo Clinic Proceedings, 2019, 94(7): 1357–1373.[28]Feuerstein JD, Isaacs KL, et al. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology, 2020, 158(5): 1450–1461.[29]Chen Y, Chen L, et al. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterology, 2020, 20(1): 192.
本站是提供個人知識琯理的網絡存儲空間，所有內容均由用戶發佈，不代表本站觀點。請注意甄別內容中的聯系方式、誘導購買等信息，謹防詐騙。如發現有害或侵權內容，請點擊一鍵擧報。